by The global Anti-acne Cosmetics market size is expected to be worth around US$ 10.90 billion by 2030, according to a new report by Vision Research Reports.
The global Anti-acne Cosmetics market size was valued at US$ 5.47 billion in 2020 and is anticipated to grow at a CAGR of 10.1% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39047
Table of Contents
Anti-acne Cosmetics Market Growth Factors
The high psychological burden associated with acne, especially among women, is expected to be the key growth-driving factor for the market. Moreover, the easy availability of various products to treat acne is anticipated to support the market growth. According to the American Academy of Dermatology, it is one of the common skin disorders in the U.S., affecting approximately 50 million individuals every year, with nearly 85% of individuals between the age group of 12 and 24 years having minor acne. Thus, a high prevalence of this skin disorder is also anticipated to fuel the product demand, thereby augmenting the market growth.
According to a study conducted by SkinStore, an average American woman uses nearly 16 skincare products per day and spends approximately USD 8 each day on facial cosmetics products. Such beauty regimes are also anticipated to propel market growth.
Anti-acne Cosmetics Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 10.90 billion by 2030 |
| Growth Rate | CAGR of 10.1% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product type, Gender, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | PCA; Obaji; PHYTOMER; Skin Medica; Skin Better Science; Colorescience; Sente; Jan Marini Skin Research; Revision Skincare; The BeautyHealth Company; Glow Biotics; Perricone MD |
By Product Type Analysis
On the basis of product, the market is divided into masks, creams & lotions, cleansers & toners, and others. The creams & lotions segment accounted for the maximum share of more than 40% in 2020 owing to the high demand by both men and women.
The others segment include products, such as face washes, gels, serums, and essential oils. The others segment is anticipated to grow at the fastest CAGR during the forecast period due to the compatibility of these products with various skin types and better skin absorption of these products.
By Gender Analysis
The women segment dominated the market in 2020 with a share of over 52%. The segment is expected to expand further at the fastest CAGR over the forecast period.
According to a survey, 62.2% of pre-menopausal women reported worsening of acne during the menstrual cycle. The men segment held a substantial share in 2020.
By End-use Analysis
The Medspa segment accounted for the highest revenue share of more than 62.5% in 2020. The segment is also anticipated to register the fastest CAGR over the forecast period.
The millennial population is the largest target demographic for medical-grade skincare brands. According to the American Spa Association, the revenue of the Medspa industry in the U.S has witnessed a double-digit growth since 2010, and the majority of the Medspa patients were between the ages of 35-54 years.
The number of dermatology clinics is also on the rise globally due to the increasing incidences of skin cancer and lifestyle-related skin conditions, such as acne, atopic dermatitis, and hyperpigmentation.
By Regional Analysis
Asia Pacific dominated the market in 2020 with a revenue share of more than 39% and is estimated to witness lucrative growth over the forecast period. Asia Pacific is the largest potential export market for U.S.-based products owing to over 3 billion potential consumers of anti-acne cosmetic products.
Australia, Japan, and South Korea, are some of the largest consumers of well-established U.S.-based products. In addition, Vietnam, Malaysia, and Indonesia are a few other regions expected to witness the demand for these products in the forecast period.
Read also @ Synthetic Biology Market Insight and Trends 2030
Major Key Players Covered in The Anti-acne Cosmetics Market Report include
- PCA
- Obaji
- PHYTOMER
- Skin Medica
- Skin Better Science
- Colorescience
- Sente
- Jan Marini Skin Research
- Revision Skincare
- The BeautyHealth Company
- Glow Biotics
- Perricone MD
Anti-acne Cosmetics Market Segmentation
- By Product Type
- Mask
- Creams & Lotions
- Cleansers & Toners
- Others
- By Gender
- Women
- Men
- By End-use
- Dermatology Clinics
- Medspa
- Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Anti-acne Cosmetics Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Anti-acne Cosmetics Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Anti-acne Cosmetics Market, By Capacitor
7.1. Anti-acne Cosmetics Market, by Capacitor, 2021-2030
7.1.1. Mask
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Creams & Lotions
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Cleansers & Toners
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Anti-acne Cosmetics Market, By Gender
8.1. Anti-acne Cosmetics Market, by Gender, 2021-2030
8.1.1. Women
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Men
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Anti-acne Cosmetics Market, By End User
9.1. Anti-acne Cosmetics Market, by End User, 2021-2030
9.1.1. Dermatology Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medspa
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Anti-acne Cosmetics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.2. Market Revenue and Forecast, by Gender (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.2. Market Revenue and Forecast, by Gender (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Gender (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Gender (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.2. Market Revenue and Forecast, by Gender (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Gender (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Gender (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Gender (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Gender (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Gender (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Gender (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. PCA
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Obaji
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. PHYTOMER
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Skin Medica
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Skin Better Science
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Colorescience
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Sente
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Jan Marini Skin Research
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Revision Skincare
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. The BeautyHealth Company
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39047
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
